Cargando…
Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugs
Multidrug resistance MDR proteins (MRPs) are members of the C family of a group of proteins named ATP binding cassette (ABC) transporters. MRPs can transport drugs including anticancer drugs, nucleoside analogs, antimetabolites and tyrosine kinase inhibitors. Drugs used in HCC therapy, such as tyros...
Autores principales: | Fouquet, Grégory, Debuysscher, Véronique, Ouled-Haddou, Hakim, Eugenio, Mélanie Simoes, Demey, Baptiste, Singh, Amrathlal Rabbind, Ossart, Christèle, Bagami, Mohammed Al, Regimbeau, Jean-Marc, Nguyen-Khac, Eric, Naassila, Mickael, Marcq, Ingrid, Bouhlal, Hicham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078028/ https://www.ncbi.nlm.nih.gov/pubmed/27081035 http://dx.doi.org/10.18632/oncotarget.8679 |
Ejemplares similares
-
RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation
por: Bouhlal, Hicham, et al.
Publicado: (2016) -
Identification of SLAMF3 (CD229) as an Inhibitor of Hepatocellular Carcinoma Cell Proliferation and Tumour Progression
por: Marcq, Ingrid, et al.
Publicado: (2013) -
Mechanisms of chronic alcohol exposure-induced aggressiveness in cellular model of HCC and recovery after alcohol withdrawal
por: Marié, Constance, et al.
Publicado: (2022) -
Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition
por: Fouquet, Grégory, et al.
Publicado: (2022) -
Signaling lymphocytic activation molecules Slam and cancers: friends or foes?
por: Fouquet, Gregory, et al.
Publicado: (2018)